Novartis Capital Corporation, founded in 1996 and headquartered in New York City, serves as a vital finance arm for its parent company Novartis AG, which is based in Basel, Switzerland. The corporation primarily focuses on providing financing solutions to support the operational and strategic needs of its parent company's pharmaceutical and healthcare endeavors.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Novartis Capital Corporation commenced its bond issuance in 1997, establishing itself as a key player in the corporate bond market. Notable issuances include a $1.5 billion bond in 2020 aimed at refinancing existing debt, which attracted significant investor interest due to its competitive yield of 1.85%, well below the industry average. Continuing to innovate, Novartis offers bonds with options for sustainable financing, reflecting the company's commitment to corporate social responsibility. As of October 2023, recent yields on their bonds remain attractive, making them an appealing choice for retail investors seeking exposure in the healthcare sector.